₹ 1,605.80
-59.80 (-3.59%)
T
Tatva Chintan Pharma
₹ 1,605.80
TATVA Financials Summary (Consolidated)
Tatva Chintan Pharma revenue increased 29.03% quarter-on-quarter to ₹219 Cr in Sep 2026, while net profit increased 34.38% quarter-on-quarter to ₹22 Cr. Compared to the same quarter last year, revenue is up 75.98% and net profit is up 117.17%. EPS for the quarter stood at ₹9.17, increased from ₹6.83 in the previous quarter and up from ₹4.24 a year ago.
Tatva Chintan Pharma Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of TATVA Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
TATVA Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






